Effects of selenium on radiation responses of tumor cells and tissue

Strahlentherapie und Onkologie

Volumn 182, Issue 12, 2006, Pages 693-695

  Dörr, Wolfgang ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Radioprotection; Selenium; Tumors

Indexed keywords

IRINOTECAN; SELENITE; SELENIUM; SELENIUM DERIVATIVE;

ANIMAL CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLONOGENESIS; CLONOGENIC ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; RADIATION PROTECTION; RADIATION RESPONSE; RAT; REVIEW; TUMOR CELL;

ANIMALS; APOPTOSIS; CELL SURVIVAL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MICE; NEOPLASM TRANSPLANTATION; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RATS; RHABDOMYOSARCOMA; SELENIUM COMPOUNDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 33845355540     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1595-8     Document Type: Review

References (31)

1. Apostolou S, Klein JO, Mitsuuchi Y, et al. Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene 2004;23:5032-40.
2. Baumann M, Liertz C, Baisch H, et al. Impact of overall treatment time of fractionated irradiation on local control of human FaDu squamous cell carcinoma in nude mice. Radiother Oncol 1994;32:137-43.
3. Beck-Bornholdt HP, Omniczynski M, Theis E, et al. Influence of treatment time on the response of rat rhabdomyosarcoma R1H to fractionated irradiation. Acta Oncol 1991;30:57-63.
4. Breccia A, Badiello R, Trenta A, et al. On the chemical radioprotection by organic selenium compounds in vivo. Radiat Res 1969;38:483-92.
5. Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer [Erratum in: J Clin Oncol 2000;18:4110-1]. J Clin Oncol 2000;18:3339-45.
6. Cao S, Durrani FA, Rustum YM. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 2004;10:2561-9.
7. Celik HA, Aydin HH, Deveci R, et al. Biochemical and morphological characteristics of selenite-induced apoptosis in human hepatoma Hep G2 cells. Biol Trace Elem Res 2004;99:27-40.
8. Fehlauer F, Tribius S, Alberti W, et al. Late effects and cosmetic results of conventional versus hypofractionated irradiation in breast-conserving therapy. Strahlenther Onkol 2005;181:625-31.
9. Gehrisch A, Dörr W. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol (in press).
10. Gopee N V, Johnson VJ, Sharma RP. Sodium selenite-induced apoptosis in murine B-lymphoma cells is associated with inhibition of protein kinase C-delta, nuclear factor kappaB, and inhibitor of apoptosis protein. Toxicol Sci 2004;78:204-14.
11. Gosh J. Rapid induction of apoptosis in prostate cancer cells by selenium: reversal by metabolites of arachidonate 5-lipoxygenase. Biochem Biophys Res Commun 2004;315:624-35.
12. Hartmann A, Vormstein M, Schnabel T, et al. An absent correlation between antioxidant blood concentrations and the remission response of preoperatively treated breast carcinomas. Strahlenther Onkol 1996;172:434-8.
13. Hille A, Schmidberger H, Tows N, et al. The impact of varying volumes in rectal balloons on rectal dose sparing in conformal radiation therapy of prostate cancer. A prospective three-dimensional analysis. Strahlenther Onkol 2005;181:709-16.
14. Husbeck B, Nonn L, Peehl DM, et al. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Prostate 2006;66:218-25.
15. Husbeck B, Peehl DM, Knox SJ. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic Biol Med 2005;38:50-7.
16. Jiang C, Hu H, Malewicz B, et al. Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol Cancer Ther 2004;3:877-84.
17. Jonsson-Videsater K, Bjorkhem-Bergmann L, Hossain A, et al. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Biochem Pharmacol 2004;67:513-22.
18. Kouloulias VE, Kouvaris JR, Pissakas G, et al. A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity. Strahlenther Onkol 2004;180:557-62.
19. Kouloulias VE, Kouvaris JR, Pissakas G, et al. Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: topical intrarectal versus subcutaneous application. Int J Radiat Oncol Biol Phys 2005;62:486-93.
20. Kummermehr J, Dörr W, Trott KR. Kinetics of accelerated repopulation in normal and malignant squamous epithelia during fractionated radiotherapy. Br J Radiol Suppl 1992;24:193-9.
21. Müller AC, Pigorsch S, Beyer C, et al. Radioprotective effects of amifostine in vitro and in vivo measured with the comet assay. Strahlenther Onkol 2004;180:517-25.
22. Philipov P, Tzatchev K. Selenium in the treatment of patients with brain gliomas. A pilot study. Zentralbl Neurochir 1990;51:145-6.
23. Sagowski C, Tesche S, Zywietz F, et al. The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. Onkologie 2004;27:54-7.
24. Schueller P, Puettmann S, Micke O, et al. Selenium influences the radiation sensitivity of C6 rat glioma cells. Anticancer Res 2004;24:2913-7.
25. Stone HB, Moulder JE, Coleman CN, et al. Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003. Radiat Res 2004;162:711-28.
26. Trott KR, Kummermehr J. The time factor and repopulation in tumors and normal tissues. Semin Radiat Oncol 1993;3:115-25.
27. Vacha P, Fehlhauer F, Mahlmann B, et al. Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection? Strahlenther Onkol 2003;179:385-9.
28. Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann NY Acad Sci 2000;899:44-60.
29. Weiss JF, Srinivasan V, Kumar KS, et al. Radioprotection by metals: selenium. Adv Space Res 1992;12:223-31.
30. Zhong W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001;61:7071-8.
31. Zuo L, Yang Y, Wang X, et al. Sodium selenite induces apoptosis in acute promyelotic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann Hematol 2004;83:751-8.